Treatment of Drug-Eluting Stent Restenosis. The New Pilgrimage: Quo Vadis?

Journal of the American College of Cardiology

Volumn 55, Issue 24, 2010, Pages 2717-2720

  Alfonso, Fernando ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

drug eluting stent; in stent restenosis; randomized trial; resistance; sirolimus

Indexed keywords

CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

ANGIOGRAPHY; BARE METAL STENT; DRUG ELUTING STENT; EDITORIAL; HUMAN; IN-STENT RESTENOSIS; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; INTRAVASCULAR ULTRASOUND; OBSERVATIONAL STUDY; PRIORITY JOURNAL; STENT THROMBOSIS;

CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL REVASCULARIZATION; PROSTHESIS FAILURE; RECURRENCE;

EID: 77953106331     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.03.026     Document Type: Editorial

References (19)

1. Kastrati A., Mehilli J., von Beckerath N., et al. Sirolimus-eluting stent or paclitaxel-eluting stent versus balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293 (2005) 165-171
2. Alfonso F., Pérez-Vizcayno M.J., Hernández R., et al. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol 47 (2006) 2152-2160
3. Baz J.A., Pinar E., Albarrán A., Mauri J., and Spanish Cardiac Catheterization and Coronary Intervention Registry. 17th official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2007). Rev Esp Cardiol 61 (2008) 1298-1314
4. Alfonso F., Perez-Vizcayno M.J., Cruz A., et al. Treatment of patients with in-stent restenosis. EuroIntervention Suppl D (2009) 70-78
5. Cosgrave J., Melzi G., Biondi-Zoccai G.G.L., et al. Drug-eluting stent restenosis: the pattern predicts the outcome. J Am Coll Cardiol 47 (2006) 2399-2404
6. Fujii K., Mintz G.S., Kobayashi Y., et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 109 (2004) 1085-1088
7. Gonzalo N., Serruys P.W., Okamura T., et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 158 (2009) 284-293
8. Steinberg D.H., Gaglia Jr. M.A., Pinto Slottow T.L., et al. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol 103 (2009) 491-495
9. Lemos P.A., van Mieghem C.A., Arampatzis C.A., et al. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes. Circulation 109 (2004) 2500-2502
10. Kim Y.H., Lee B.K., Park D.W., et al. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis. Am J Cardiol 98 (2006) 1451-1454
11. Cosgrave J., Melzi G., Corbett S., et al. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent. Am Heart J 153 (2007) 354-359
12. Garg S., Smith K., Torguson R., et al. Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent. Cathet Cardiovasc Interv 70 (2007) 9-14
13. Mishkel G.J., Moore A.L., Markwell S., Shelton M.C., and Shelton M.E. Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents. J Am Coll Cardiol 49 (2007) 181-184
14. Sardella G., Colantonio R., De Luca L., et al. Comparison between balloon angioplasty and additional coronary stent implantation for the treatment of drug-eluting stent restenosis: 18-month clinical outcomes. J Cardiovasc Med 10 (2009) 469-473
15. Liistro F., Fineschi M., Grotti S., et al. Long-term clinical outcome of alternative treatment strategies for drug-eluting stents restenosis. EuroIntervention 5 (2009) 454-459
16. Mehilli J., Byrne R.A., Tiroch K., et al., ISAR-DESIRE 2 Investigators. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. J Am Coll Cardiol 55 (2010) 2710-2716
17. Alfonso F., García J., Pérez-Vizcayno M.J., et al. New stent implantation for recurrences after stenting for in-stent restenosis: implications of a third metal layer in human coronary arteries. J Am Coll Cardiol 54 (2009) 1036-1038
18. Scheller B., Hehrlein C., Bocksch W., et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 355 (2006) 2113-2124
19. Unverdorben M., Vallbracht C., Cremers B., et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 119 (2009) 2986-2994